MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
Condition(s):Paranoid SchizophreniaLast Updated:August 3, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Paranoid SchizophreniaLast Updated:August 3, 2015Completed
Condition(s):Paranoid Schizophrenia; SchizophreniaLast Updated:August 21, 2015Completed
Condition(s):SchizophreniaLast Updated:September 21, 2023Recruiting
Condition(s):SchizophreniaLast Updated:December 19, 2017Completed
Condition(s):Paranoid Schizophrenia; Schizophrenia and Related Disorders; Schizophrenia Prodromal; Schizotypal Disorder; Paranoid Ideation; Paranoid Delusion; Ideas of Reference; Psychosis Paranoid; Psychotic Disorders; Psychotic Paranoia; Psychotic; Disorder, DelusionalLast Updated:March 19, 2024Active, not recruiting
Condition(s):Schizophrenia, Catatonic; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Schizophrenia; Psychotic DisordersLast Updated:July 7, 2010Unknown status
Condition(s):SchizophreniaLast Updated:September 12, 2012Completed
Condition(s):Paranoid DelusionsLast Updated:December 4, 2018Completed
Condition(s):Paranoia in People With Schizophrenia-spectrum DiagnosisLast Updated:March 20, 2017Completed
Condition(s):Schizophrenia, Paranoid; Schizophrenia, Disorganized; Schizophrenia, UndifferentiatedLast Updated:February 9, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.